Enhancing KCC2 function reduces interictal activity and prevents seizures in temporal lobe epilepsy
Proceedings of the National Academy of Sciences · 10.03.2026 · 123 (10)
DOI: 10.1073/pnas.2522722123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.03.2026. Verfasst von Florian Donneger und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institut du Fer à Moulin, Inserm, Sorbonne Université, UMR-S 1270, Paris 75005, France. Hauptthemen laut MEDLINE: Epilepsy, Temporal Lobe, Symporters, Seizures. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation pour la Recherche Médicale (FRM), Agence Nationale de la Recherche (ANR).
Abstract (Originalsprache)
The neuronal K/Cl cotransporter KCC2 regulates the transmembrane chloride gradient, which controls the efficacy of GABAergic signaling. In mesial temporal lobe epilepsy (mTLE) and other neurological disorders, reduced KCC2 expression or function can result in depolarizing GABA signaling, which is thought to contribute to pathological activity and seizures. Therefore, restoring chloride homeostasis represents a promising therapeutic strategy. We investigated the mechanisms and antiseizure effects of two small molecules, prochlorperazine (PCPZ) and CLP-257, that have been identified as potential KCC2 enhancers. We found that both compounds enhance KCC2 function and clustering in cortical neurons while reducing its membrane diffusion, without altering canonical regulatory phosphorylation. CLP-257 also selectively increased extrasynaptic, but not synaptic, GABA A receptor-mediated currents. Using in vitro recordings from resected brain tissue of patients with drug-resistant mTLE and in vivo recordings from a mouse model, we show that PCPZ and CLP-257 (or its prodrug CLP-290) effectively suppressed spontaneous epileptiform activity in both models. These findings reveal that PCPZ and CLP-257 act as genuine KCC2 enhancers and provide experimental evidence of the therapeutic potential of such compounds for treating drug-resistant mTLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut du Fer à Moulin, Inserm, Sorbonne Université, UMR-S 1270, Paris 75005, France.
- Sorbonne Université, Institut du Cerveau Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital de la Pitié Salpêtrière, Paris 75013, France.
- Department of Neuropathology, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris 75013, France.
- Department of Neurosurgery, Sainte-Anne Hospital, Paris 75014, France.
- Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Neurosurgery, Pitié-Salpêtrière Hospital, Paris 75013, France.
- Assistance Publique - Hôpitaux de Paris (AP-HP), Epilepsy Unit, Reference Center for Rare Epilepsies, and Department of Clinical Neurophysiology, Pitié-Salpêtrière Hospital, Paris 75013, France.
ORCID-Profile: Florian Donneger, Delphine Roussel, Carla Pagan, Manisha Sinha, Marion Russeau, Bertrand Mathon, Vincent Navarro, Jean Christophe Poncer
Förderung
- Fondation pour la Recherche Médicale (FRM)
- Agence Nationale de la Recherche (ANR)
Zitieren
APA
Donneger, F., Zanin, A., Besson, J., Roussel, D., Kadiri, Y., Pagan, C., Sinha, M., David, N., Russeau, M., Bielle, F., Devaux, B., Mathon, B., Navarro, V., Chassoux, F., & Poncer, J. C. (2026). Enhancing KCC2 function reduces interictal activity and prevents seizures in temporal lobe epilepsy. Proceedings of the National Academy of Sciences, 123(10). https://doi.org/10.1073/pnas.2522722123
Vancouver
Donneger F, Zanin A, Besson J, Roussel D, Kadiri Y, Pagan C, et al. Enhancing KCC2 function reduces interictal activity and prevents seizures in temporal lobe epilepsy. Proceedings of the National Academy of Sciences. 2026;123(10). doi:10.1073/pnas.2522722123
BibTeX
@article{Donneger2026,
author = {Donneger, Florian and Zanin, Adrien and Besson, Jeremy and Roussel, Delphine and Kadiri, Yoness and Pagan, Carla and Sinha, Manisha and David, Nicolas and Russeau, Marion and Bielle, Franck and Devaux, Bertrand and Mathon, Bertrand and Navarro, Vincent and Chassoux, Francine and Poncer, Jean Christophe},
title = {Enhancing KCC2 function reduces interictal activity and prevents seizures in temporal lobe epilepsy},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {10},
doi = {10.1073/pnas.2522722123}
}
EUVIMED